Vaccine Market: Trends, Opportunities and Competitive Analysis [2024-2030]

Vaccine Market: Trends, Opportunities and Competitive Analysis [2024-2030]

Vaccine Market Trends and Forecast

The future of the vaccine market looks promising with opportunities in the pediatrics and adults end users. The global vaccine market is expected to reach an estimated $54.6 billion by 2030 with a CAGR of -3.6% from 2023 to 2030. In the year 2021, the vaccine market witnessed significant growth due to the outbreak of coronavirus (COVID-19) pandemic. The major drivers for this market are growing prevalence of infectious diseases, increasing consumer awareness towards immunization, and introduction of vaccination programs by governments to prevent dangerous diseases or infections, including tuberculosis, cancer, hepatitis, and influence.

Technology, Product Type, Disease Indication, Route Of Administration, and End Use

A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.

Vaccine Market by Segments

Vaccine Market by Segment

The study includes trends and forecast for the global vaccine market by technology, product type, disease indication, route of administration, end use, and region, as follows:

Vaccine Market by Technology [Value ($M) Shipment Analysis from 2018 to 2030]:

Inactivated Vaccine

Live Attenuated Vaccine

Conjugate and Subunit

Toxoid Vaccine

Viral Vector

mRNA Vaccine

Other Technologies

Vaccine Market by Product Type [Value ($M) Shipment Analysis from 2018 to 2030]:

Monovalent

Multivalent

Vaccine Market by Disease Indication [Value ($M) Shipment Analysis from 2018 to 2030]:

COVID-19

Influenza

DTP

Pneumococcal Diseases

HPV

Rotavirus

Herpes Zoster

Varicella

Other Disease Indications

Vaccine Market by Route of Administration [Value ($M) Shipment Analysis from 2018 to 2030]:

Intramuscular & Subcutaneous administration

Oral administration

Others

Vaccine Market by End Use [Value ($M) Shipment Analysis from 2018 to 2030]:

Pediatrics

Adults

Vaccine Market by Region [Value ($M) Shipment Analysis from 2018 to 2030]:

North America

Europe

Asia Pacific

The Rest of the World

List of Vaccines Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, vaccine companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the vaccine companies profiled in this report include-

GlaxoSmithKline

Merck

Pfizer

Sanofi

CSL

Vaccine Market Insights

Lucintel forecasts that other technologies will remain the largest segment over the forecast period because it helps in preventing diseases like; human papillomavirus (HPV), hepatitis B, malaria, and more.

Pediatrics is expected to remain the largest end user segment due to the supportive initiatives by governments and businesses to create vaccines for pediatric population to prevent serious illness.

APAC will remain the largest region because of increasing urbanization and population expansion are factors in the rise of healthcare need.

Features of the Vaccine Market

Market Size Estimates: Vaccine market size estimation in terms of value ($M)

Trend And Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments and regions.

Segmentation Analysis: Vaccine market size by various segments, such as technology, product type, disease indication, route of administration, end use, and region

Regional Analysis: Vaccine market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.

Growth Opportunities: Analysis on growth opportunities in different technologies, product types, disease indications, routes of administration, end uses, and regions for the vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape for the vaccine market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the vaccine market size?

Answer: The global vaccine market is expected to reach an estimated $54.6 billion by 2030.

Q2. What is the growth forecast for vaccine market?

Answer: The global vaccine market is expected to grow with a CAGR of -3.6% from 2023 to 2030.

Q3. What are the major drivers influencing the growth of the vaccine market?

Answer: The major drivers for this market are growing prevalence of infectious diseases, increasing consumer awareness towards immunization, and introduction of vaccination programs by governments to prevent dangerous diseases or infections, including tuberculosis, cancer, hepatitis, and influence.

Q4. What are the major segments for vaccine market?

Answer: The future of the vaccine market looks promising with opportunities in the pediatrics and adults end use segments.

Q6. Who are the key vaccine companies?

Answer: Some of the key vaccine companies are as follows:

GlaxoSmithKline

Merck

Pfizer

Sanofi

CSL

Q7. Which vaccines segment will be the largest in the future?

Answer:Lucintel forecasts that conjugate will remain the largest technology segment over the forecast period because it helps in preventing invasive pneumococcal diseases.

Q8. In vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increasing awareness towards vaccination and supporting government policies for health welfare.

Q9. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

Q.1. What are some of the most promising, high-growth opportunities for the vaccine market by technology (conjugate, inactivated & subunit, live attenuated, recombinant, toxoid, viral vector, mRNA, viral vector, and others), product type (monovalent and multivalent), disease indication (influenza, pneumococcal diseases, combination vaccines, HPV, herpes zoster, meningococcal diseases, rotavirus, MMR, varicella, hepatitis, DTP, Polio, COVID 19, and others), route of administration (intramuscular & subcutaneous administration, oral administration, and others), end use (pediatrics and adults), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.